secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK:        0001426800
Form:       8-K
Filed at:   2026-06-05T20:00:16+00:00
Accession:  0001193125-26-259481
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Assembly Biosciences shareholders approve equity plan share increases; all director nominees elected
--------------------------------------------------------------------------------

- Amendment No. 3 to 2018 Stock Incentive Plan approved; shares reserved increased from 1,478,333 to 2,678,333 (increase of 1,200,000).
- Amendment No. 2 to Employee Stock Purchase Plan approved; shares reserved increased from 225,000 to 515,000 (increase of 290,000).
- All nine director nominees elected: Altig, Cihlar, Consylman, Cook II, Houghton, Johnson-Pratt, Mahony, McHutchison, Okazaki.
- Advisory say-on-pay approved (11,293,061 for, 5,401 against); ratification of Ernst & Young as auditor approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1426800/000119312526259481/0001193125-26-259481-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1426800/000119312526259481/asmb-20260604.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-259481

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer